A scientific study finds that receptivity to e-cigarette advertising increases the likelihood of trying conventional cigarettes one year later. The research was funded by the National Institute on Drug Abuse (NIDA), part of the National Institutes of Health, and the Center for Tobacco Products, U.S. Food and Drug Administration.
The study found that young people ages 12-21 who had never previously smoked, but were receptive to e-cigarette advertising, were 60 percent more likely to try smoking cigarettes one year later, compared to teens who were not receptive to the ads. Study participants were considered receptive to an advertisement if they reported liking or recognizing images from the ad.
The researchers analyzed data collected from 10,989 participants as part of the Population Assessment of Tobacco and Health (PATH) Study, a national representative, longitudinal study of tobacco use and how it affects the health of people in the United States. The authors conclude tobacco product advertising is a continuing contributor to tobacco use among young people and call for more research on this cross-over effect.
For a copy of the abstract, go to "Association Between Receptivity to Tobacco Advertising and Progression to Tobacco Use in Youth and Young Adults in the PATH Study," published in JAMA Pediatrics.
For more information about e-cigarettes, see NIDA’s Electronic Cigarettes (E-cigarettes) DrugFacts.
For information about cigarettes and other tobacco products, see NIDA’s Cigarettes and Other Tobacco Products DrugFacts.
For more information about the PATH Study, visit the PATH Study webpage.
NIDA Press Office
About the National Institute on Drug Abuse (NIDA): The National Institute on Drug Abuse (NIDA) is a component of the National Institutes of Health, U.S. Department of Health and Human Services. NIDA supports most of the world’s research on the health aspects of drug use and addiction. The Institute carries out a large variety of programs to inform policy, improve practice, and advance addiction science. Fact sheets on the health effects of drugs and information on NIDA research and other activities can be found at www.drugabuse.gov, which is now compatible with your smartphone, iPad or tablet. To order publications in English or Spanish, call NIDA’s DrugPubs research dissemination center at 1-877-NIDA-NIH or 240-645-0228 (TDD) or email requests to email@example.com. Online ordering is available at drugpubs.drugabuse.gov. NIDA’s media guide can be found at www.drugabuse.gov/publications/media-guide/dear-journalist, and its easy-to-read website can be found at www.easyread.drugabuse.gov. You can follow NIDA on Twitter and Facebook.
About the National Institutes of Health (NIH): NIH, the nation’s medical research agency, includes 27 Institutes and Centers and is a component of the U.S. Department of Health and Human Services. NIH is the primary federal agency conducting and supporting basic, clinical, and translational medical research, and is investigating the causes, treatments, and cures for both common and rare diseases. For more information about NIH and its programs, visit www.nih.gov.
NIH. . .Turning Discovery Into Health®